
Keywords: scFv، Fv یک زنجیره ای; Antibody engineering; AML; Leukemic cancer stem cells; Bivalent scFv (biscFv); CD123LSC, leukemic cancer stem cell; AML, acute myeloid leukemia; IL-3, interleukin-3; mAb, monoclonal antibody; scFv, single-chain Fv; ADCC, antibody-dependent cell-mediated c